News
BDSX
27.72
+1.43%
0.39
Biodesix Consensus Price Target Raised by 12.20% to $37.54
NASDAQ · 1d ago
Weekly Report: what happened at BDSX last week (0921-0925)?
Weekly Report · 5d ago
Biodesix Is Maintained at Buy by HC Wainwright & Co.
Dow Jones · 5d ago
Biodesix Price Target Raised to $38.00/Share From $27.00 by HC Wainwright & Co.
Dow Jones · 5d ago
Biodesix Reveals Two Developing MRD Solution Collaborations With Bio-Rad And Thermo Fisher
NASDAQ · 6d ago
Biodesix price target raised to $38 from $27 at H.C. Wainwright
TipRanks · 09/25 16:30
Analysts Are Bullish on These Healthcare Stocks: QuidelOrtho (QDEL), Merck & Company (MRK)
TipRanks · 09/24 13:10
Biodesix Announces Progress In Two Collaborative Programs For Tumor-informed And Tumor-naïve Molecular Residual Disease Solutions
Benzinga · 09/24 10:36
Biodesix advances two programs for Molecular Residual Disease monitoring
TipRanks · 09/24 10:15
Craig-Hallum sees potential for confusion after CMS fee schedule
TipRanks · 09/22 13:55
Analysts’ Top Healthcare Picks: Abivax SA Sponsored ADR (ABVX), Biodesix (BDSX)
TipRanks · 09/22 13:50
Weekly Report: what happened at BDSX last week (0914-0918)?
Weekly Report · 09/21 10:09
10 small-cap healthcare stocks with the strongest momentum grades
Seeking Alpha · 09/17 14:20
Small-cap stocks with strong momentum grades and triple-digit YTD gains
Seeking Alpha · 09/17 13:55
Weekly Report: what happened at BDSX last week (0907-0911)?
Weekly Report · 09/14 10:13
Biodesix: Growing Fast While Trading Below Many Diagnostics Peers
Seeking Alpha · 09/10 10:09
Weekly Report: what happened at BDSX last week (0831-0904)?
Weekly Report · 09/07 10:07
Biodesix to Participate in Upcoming Investor Conferences
Barchart · 09/03 05:00
What Makes Biodesix, Inc. (BDSX) a Strong Momentum Stock: Buy Now?
NASDAQ · 08/31 16:00
Wall Street Analysts See a 26.72% Upside in Biodesix (BDSX): Can the Stock Really Move This High?
NASDAQ · 08/31 13:55
More
Webull provides a variety of real-time BDSX stock news. You can receive the latest news about BIODESIX INC through multiple platforms. This information may help you make smarter investment decisions.
About BDSX
Biodesix, Inc. is a diagnostic solutions company. The Company's business includes Biodesix Lung Diagnostic Testing and Biodesix Development Services. Its Biodesix Lung Diagnostic Testing provides lung diagnostic testing services for healthcare providers through five blood-based tests. Its Biodesix Development Services supports global biopharmaceutical, life sciences, and research institutions with scientific, technological, and operational capabilities that enable the development of diagnostic tests, tools, and therapeutics. The Company offers Nodify Lung tests and IQLung tests that assess cancer risk and provide treatment guidance following a lung cancer diagnosis. The Nodify Lung tests include Nodify CDT and Nodify XL2 tests, which evaluate the risk of lung cancer in lung nodules. The GeneStrat ddPCR, GeneStrat NGS, and VeriStrat tests are used in the diagnosis of lung cancer to detect tumor mutations and assess the patient’s immune system status.